Showing results (181-190 of 207) with videos related to

Sort By:
Pageof 21
European Journal of Cancer (Oxford, England : 1990)|September 24, 1999
Chemotherapy for operable gastric cancer: results of the Dutch randomised FAMTX trial. The Dutch Gastric Cancer Group (DGCG)I Songun, H J Keizer, J Hermans, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Long-term follow-up of non-seminomatous testicular cancer patients with mature teratoma or carcinoma at postchemotherapy surgery. EORTC Genitourinary Tract Cancer Cooperative Group (EORTC GU Group)R L Jansen, R Sylvester, D T Sleyfer, et al.
Journal of Clinical Pharmacology|January 25, 2007
Extended thiopurine metabolite assessment during 6-thioguanine therapy for immunomodulation in Crohn's diseaseN K H de Boer, L J J Derijks, J J Keizer-Garritsen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
Trimetrexate as biochemical modulator of 5-fluorouracil/leucovorin in advanced colorectal cancer: final results of a randomised European studyC J A Punt, H J Keizer, J Douma, et al.
Antimicrobial Resistance and Infection Control|August 2, 2019
Cross-border comparison of antimicrobial resistance (AMR) and AMR prevention measures: the healthcare workers' perspectiveJ Keizer, L M A Braakman-Jansen, S Kampmeier, et al.
Clinical Pharmacokinetics|July 29, 2020
Model-Informed Precision Dosing of Everolimus: External Validation in Adult Renal Transplant RecipientsTom C Zwart, Dirk Jan A R Moes, Paul J M van der Boog, et al.
Antimicrobial Resistance and Infection Control|August 16, 2019
Correction to: Cross-border comparison of antimicrobial resistance (AMR) and AMR prevention measures: the healthcare workers' perspectiveJ Keizer, L M A Braakman-Jansen, S Kampmeier, et al.
The Netherlands Journal of Medicine|June 1, 1992
A randomized trial of two doses of granisetron in the treatment of chemotherapy-induced emesis. Dutch results within a multinational studyM W Bots, H J Dijkstra, G H Blijham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000
Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma GroupA Le Cesne, I Judson, D Crowther, et al.
European Journal of Drug Metabolism and Pharmacokinetics|June 15, 2023
Early At-Home Measurement of Adalimumab Concentrations to Guide Anti-TNF Precision Dosing: A Pilot StudyPaul A G de Klaver, Ron J Keizer, Rob Ter Heine, et al.
Pageof 21